首页> 外国专利> METHOD OF SURGICAL TREATMENT OF VASOMOTOR RHINITIS

METHOD OF SURGICAL TREATMENT OF VASOMOTOR RHINITIS

机译:血管性鼻炎的外科治疗方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to otolaryngology and can be applied in treatment of vasomotor rhinitis. Essence of method lies in argon-plasma destruction of cavernous plexuses in lower layer of nasal turbinate mucosa without injuring ciliary epithelium and bone lamella of turbinate. Local terminal anesthesia is performed by placing on both sides of lower nasal turbinates tampon soaked with 5% trimecaine hydrochloride solution or 10% lidocaine hydrochloride solution with further tampon removal in 4-5 min. Infiltration anesthesia is performed by introduction of 1% lidocaine hydrochloride or 1% novocaine hydrochloride into each lower nasal turbinate. Anesthetic is first introduced into medial and posterior parts of lower nasal turbinate through sticking anesthesiologic needle into middle of turbinate surface, then anesthetic is introduced into anterior part of lower nasal turbinate through sticking anesthesiologic needle into anterior turbinate surface. On upper surface of lower nasal turbinates puncture is made - mucosa canal with submucosa to bone, starting from anterior end of turbinate and to its posterior end, without puncturing mucosa of posterior end outwards. Flexible tip of plasma-destructor is introduced into canal to posterior end of lower nasal turbinate, through it immediately defocused flow of ionised argon plasma is supplied and process of argon-plasma uniform destruction of cavernous plexuses of submucosal layer of lower nasal turbinate is performed in axial and radial directions. Plasma-destructor tip is gradually during 5-7 sec removed from canal, by moving defocused flow of ionised argon plasma from coagulated parts to bleeding or insufficiently coagulated tissue zones. When plasma-destructor tip is removed from canal, puncture place is welded and supply of ionised argon plasma flow is stopped, then process is repeated on second lower nasal turbinate.;EFFECT: application of claimed invention allows to achieve reduction of nasal resistance to jet of air breathed out by patient, reduce time necessary to achieve required rate of mucociliary transport, stabilise nasal breathing, increase degree of ciliary epithelium preservation, eliminate formation of areas of new hemorrhages.;3 cl, 3 ex
机译:技术领域本发明涉及医学,即耳鼻喉科,可用于治疗血管舒缩性鼻炎。该方法的实质在于,在不损害睫状上皮和鼻甲骨片的情况下,在鼻甲下层粘膜下层海绵体神经丛的氩等离子体破坏。局部终末麻醉是通过将下鼻甲的棉塞放在用5%盐酸曲美卡因溶液或10%盐酸利多卡因溶液浸泡的鼻塞的两侧进行,并在4-5分钟内进一步去除棉塞。渗透麻醉是通过将1%盐酸利多卡因或1%盐酸诺夫卡因引入每个下部鼻甲中进行的。首先通过将麻醉针刺入鼻甲表面中部将麻醉剂引入下鼻甲的内侧和后部,然后通过将麻醉针刺入鼻甲前表面将麻醉剂引入下鼻甲的前部。在下鼻甲的上表面进行穿刺-从鼻甲的前端开始一直到其后端的粘膜下层粘膜下层到骨头,而不向外刺破后端的粘膜。将血浆破坏因子的柔性尖端引入下鼻甲的鼻腔,通过它立即提供离焦的电离氩等离子体流,并在鼻下鼻甲的黏膜下层的海绵状丛中进行氩-血浆均匀破坏的过程。轴向和径向。通过将离焦的离子化氩气流从凝固部位移至出血或凝固不充分的组织区域,在5-7秒钟内逐渐从血浆中去除血浆破坏者尖端。当从导管中取出血浆破坏剂尖端时,将其穿刺位置焊接好,并停止供应氩离子流,然后在第二个下鼻甲处重复该过程。效果:本发明的应用可以降低鼻腔对射流的抵抗力患者呼出的空气量减少,以达到达到所需的粘膜纤毛运输速度所需的时间,稳定鼻呼吸,增加睫状上皮的保存度,消除新的出血区域的形成; 3 cl,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号